Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Artificial Intelligence In Epidemiology Market Forecast: Value Set To Climb From $1.09 Billion To $3.17 Billion
The artificial intelligence in epidemiology market has experienced rapid expansion in recent years. Its valuation is projected to increase from $0.83 billion in 2025 to $1.09 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 30.0%. This historical expansion is primarily due to factors such as the rise in infectious disease outbreaks, greater access to health data, the integration of digital public health tools, heightened governmental emphasis on disease surveillance, and the imperative for more rapid outbreak responses.
The artificial intelligence in epidemiology market size is anticipated to experience substantial growth over the next few years. It is projected to reach a value of $3.17 billion by 2030, expanding at a compound annual growth rate (CAGR) of 30.7%. This increase during the forecast period is driven by factors such as growing investments in AI for public health, the expansion of cloud-based epidemiology platforms, an increasing need for early warning systems, the integration of various health data sources, and a strong focus on pandemic preparedness. Prominent trends expected in this period encompass AI-driven disease outbreak prediction, real-time epidemiological surveillance systems, advanced population health analytics, predictive modeling for public health planning, and integrated data platforms for epidemiology.
Get A Free Sample Report With In-Depth Market Insights:
Artificial Intelligence In Epidemiology Market Growth Factors: What’s Supporting Expansion?
The increasing prevalence of chronic illnesses is anticipated to drive the expansion of artificial intelligence in the epidemiology market moving ahead. Chronic disease is defined as a persistent or long-term health condition, typically enduring for at least three months, which can progressively deteriorate. AI holds a crucial function across diverse facets of chronic disease epidemiology, encompassing risk assessment, modeling disease progression, early identification, and diagnosis. For example, data from May 2023, reported by The United Nations (UN) – a US-based intergovernmental body focused on international cooperation, peace, and security – indicates that chronic diseases account for seven out of 10 deaths in the US, resulting in over 1.7 million American fatalities annually. Consequently, the escalating burden of chronic diseases is projected to stimulate the growth of artificial intelligence in the epidemiology market.
Artificial Intelligence In Epidemiology Market Segment Landscape: Which Areas Lead Development?
The artificial intelligence in epidemiology market covered in this report is segmented –
1) By Component: Software, Services
2) By Deployment: Web-Based, Cloud-Based
3) By Application: Infection Prediction And Forecasting, Disease And Syndromic Surveillance
4) By End-Use: Government And State Agencies, Research Laboratories, Pharmaceutical And Biotechnology Companies, Healthcare Providers
Subsegments:
1) By Software: Data Analytics Platforms, Predictive Modeling Tools, Geographic Information Systems (GIS), Surveillance Systems, Reporting And Visualization Tools
2) By Services: Consulting Services, Implementation And Integration Services, Data Management And Support Services, Training And Capacity Building Services
Artificial Intelligence In Epidemiology Market Industry Trends: What’s Reshaping Demand?
Major companies within the artificial intelligence in epidemiology market are primarily focused on developing innovative technologies, such as AI-driven imaging platforms for disease management, to secure their market presence. For example, in April 2023, Twinn Health, a US-based company involved in fitness, AI, and machine learning, introduced an AI-driven imaging platform aimed at the early detection of age-related diseases. This new platform is notable as the first to integrate magnetic resonance imaging (MRI) data for assessing the risk of frailty. It functions as an effective tool for early intervention and prevention, given its ability to identify chronic age-related disorders sooner than conventional molecular signals and facilitate the management of these conditions from an early stage.
Artificial Intelligence In Epidemiology Market Industry Leaders And Competitive Landscape
Major companies operating in the artificial intelligence in epidemiology market are Alphabet Inc.; Microsoft Corporation; Roche Holding AG; Pfizer Inc.; Johnson & Johnson Services Inc.; Amazon Web Services Inc.; Google LLC; Intel Corporation; IBM Corporation; Merck & Co. Inc.; Novartis International AG; Sanofi S.A; Bristol Myers Squibb Company; AstraZeneca PLC; Oracle Corporation; GlaxoSmithKline plc; NVIDIA Corporation; Bayer Healthcare; Siemens Healthineers AG; Koninklijke Philips N.V.; SAS Institute Inc.; Epic Systems Corporation; Cerner Corporation; eClinicalWorks LLC; Meditech; Komodo Health; Metabiota Inc.
View The Full Artificial Intelligence In Epidemiology Market Report:
Artificial Intelligence In Epidemiology Market Largest Region: Which Geography Holds The Biggest Share?
North America was the largest region in the artificial intelligence in epidemiology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in epidemiology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
